# Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes

> **NCT00232375** · NA · COMPLETED · sponsor: **Tokyo Study Group** · enrollment: 42 (—)

## Conditions studied

- GAD Ab Positive Clinically Type 2 Diabetic Patients

## Interventions

- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT00232375
- **Lead sponsor:** Tokyo Study Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-01
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** 42 (—)
- **Last updated:** 2005-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232375, "Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00232375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*